Amanta Healthcare has received Securities and Exchange Board of India’s (SEBI) go-ahead to raise funds through initial public offering (IPO). The company is looking to mobilise funds through its initial share sale, entirely a fresh issuance of up to 1.25 crore equity shares.
The company proposes to utilize Rs 7,000 lakh of its net proceeds for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat and Rs 3,000 lakh for funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new line for SVP at Hariyala, Kheda, Gujarat. The shares of the company are proposed to be listed on the BSE and the NSE.
Amanta manufactures medical devices and sterile liquid products - parenteral products, which are used in cases where patients cannot intake drugs through the oral route or when the drugs are not suitable for oral intake.
